Skip to content

Dutasteride vs Finasteride: side-by-side comparison

Ancillary

Avodart · Dut · Duta

A dual 5-alpha reductase inhibitor that blocks both Type I and Type II isoenzymes, reducing serum DHT by roughly 90-94% at steady state (FDA trial median; some sources cite up to ~98%), versus ~70% with finasteride. More potent than finasteride for hair loss prevention but with a very long half-life of ~5 weeks. Clinically superior to finasteride for hair count and growth in head-to-head trials. Same caveats apply: only works with testosterone-based compounds, not DHT derivatives, and worsens nandrolone-related hair loss.

1.0/10 natty
Full breakdown →
VS
Ancillary

Propecia · Proscar · Fin

A 5-alpha reductase inhibitor that blocks the conversion of testosterone to DHT, reducing serum DHT by 65-70%. Used during testosterone cycles to prevent DHT-related hair loss. CRITICAL: Only works with testosterone-based compounds. Does NOT work with DHT derivatives (Masteron, Winstrol, Anavar). Makes hair loss WORSE with nandrolone compounds.

1.0/10 natty
Full breakdown →

1 / 10 natty scale / 1

Same lane

Both sit in the same class and are run for health. This is a like-for-like comparison: read the gaps as real trade-offs.

The tape

Core ratings

The same three rulers every entry on the site is scored with, read head to head.

DutasterideFinasteride
1.0

Natty scale

1 natural · 10 heavy

1.0
4.5

Effectiveness

Documented effect · of 5Δ0.5

4.0
2.5

Side-effect severity

Documented burden · of 5

2.5

Cost side

Body-load fingerprint

Where each one actually lands its strain, on the calculator's thirteen channels. Tap a row for what it means and which labs track it.

DutasterideFinasteride

Hormonal

Systemic

Bars show strain at each one's typical protocol, not your dose. marks values inferred from side-effect data or category rather than hand-graded. For your numbers, run the calculator.

Logistics

The vitals

DutasterideFinasteride
Ancillary
Classmatch
Ancillary
Oral
Routematch
Oral
0.5 mg/dayOnce daily, or 2-3x weekly (both effective due to long half-life)
Typical dose
1-5 mg/dayOnce daily
~5 weeks
Half-life
5-6 hours (plasma)
24-52 weeks
Typical run
12-52 weeks
Prescription only
Legal statusmatch
Prescription only
Not prohibited
WADAmatch
Not prohibited

Benefit side

What each is for

Shared goals carry both dots; a goal with one dot belongs to that side alone.

DutasterideFinasteride
HealthCosmetic

Run for

Superior Hair Loss PreventionA 917-man phase III trial (Gubelin Harcha et al., 2014, J Am Acad Dermatol) found dutasteride 0.5mg significantly superior to finasteride 1mg for hair count (P=.003), hair width (P=.004), and investigator photographic assessment (P=.002).
Maximum DHT SuppressionReduces serum DHT by roughly 90-94% (FDA trial median; up to ~98% in some sources) vs finasteride's ~70%. For those who need maximum DHT suppression.
Prostate ProtectionReduces prostatic DHT by 97-99%. FDA-approved for BPH.
Less Frequent Dosing OptionDue to 5-week half-life, twice or thrice weekly dosing is effective and may reduce side effect frequency.

Documented upside

  • Reduces serum DHT by roughly 90-94% (FDA trial median; up to ~98% in some sources), vs ~70% with finasteride
  • Inhibits both Type I and Type II 5-alpha reductase
  • Commonly cited as ~3x more potent than finasteride at Type II inhibition, ~100x at Type I
  • Clinically superior hair count results vs finasteride in a 917-man phase III trial (P=.003)
  • Can be dosed 2-3x weekly due to long half-life
+2 more on the full page

Run for

Hair Loss Prevention During Testosterone CyclesBlocks conversion of testosterone to DHT, preventing DHT-mediated hair follicle miniaturization. Only effective with testosterone-based compounds.
Prostate ProtectionReduces prostatic DHT by 80-90%. PCPT trial showed 25% reduction in prostate cancer risk. Prevents testosterone-induced prostate enlargement.
Preserving Testosterone LevelsBy blocking DHT conversion, may increase circulating testosterone by ~15%, remaining within the normal physiologic range.

Documented upside

  • Reduces serum DHT by 65-70%
  • FDA Propecia 5-year trials: 90% of men had no further hair loss (48% regrowth, 42% no change)
  • May increase circulating testosterone by ~15% (still within physiologic range)
  • Does NOT impair muscle gains from testosterone (12-month RCT confirmed)
  • 25% reduction in prostate cancer risk (PCPT trial)
+3 more on the full page

The downsides

Side effects, aligned

Each entry's documented side effects, sorted onto the same body systems so the gaps and the overlaps are visible. Tap any effect for the detail.

DutasterideFinasteride
Estrogenic
Mood, sleep & CNS
Suppression & fertility

None documented

Other documented effects

The exit

Hormonal fallout & recovery

What each does to your own hormone axis while on, and what leaving it costs.

DutasterideFinasteride
none
HPTA suppression
none
none
Aromatization
none
none
Liver toxicity
none
none
Hair-loss risk
none
No
DHT-derived
No
No
19-nor / progestogenic
No
Not required
PCT
Not required
Support role
What sticks
Support role

Dutasteride

Does not affect HPT axis directly. No PCT required. Very long half-life means effects persist months after stopping.

Finasteride

Does not affect HPT axis directly. No PCT required. Can be used long-term. May slightly increase testosterone by blocking DHT conversion.

Read-out

How they separate

  1. 01

    Enhancement

    They land at almost the same point on the natty scale (1/10 vs 1/10): a similar distance beyond natural.

  2. 02

    Body load

    The widest gap at typical protocols is shutdown depth (Dutasteride 3.2/10 vs 0/10).

  3. 03

    Coming off

    Neither requires PCT: both leave the natural testosterone axis running.

  4. 04

    Logistics

    typical runs are 24-52 weeks vs 12-52 weeks.

Generated from each entry's data file. Descriptive, not a recommendation; nothing here is medical advice.